(Q51468514)

5 April 2018

title

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. (English)

1 reference

5 April 2018

1 reference

placebo-controlled trial

1 reference

1 reference

Peter J Connelly

1

1 reference

5 April 2018

Neil P Prentice

series ordinal

2

1 reference

5 April 2018

Gary Cousland

series ordinal

3

1 reference

5 April 2018

Jim Bonham

series ordinal

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 February 2008

1 reference

5 April 2018

International Journal of Geriatric Psychiatry

published in

1 reference

5 April 2018

volume

23

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

155-160

1 reference

5 April 2018

Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study

cites work

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients).

21 January 2018

1 reference

Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages

21 January 2018

1 reference

7 January 2021

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

1 reference

7 January 2021

Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia

1 reference

7 January 2021

Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease

1 reference

7 January 2021

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

1 reference

7 January 2021

1 reference

7 January 2021

Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity

1 reference

7 January 2021

Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease

1 reference

7 January 2021

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

1 reference

7 January 2021

A controlled trial of homocysteine lowering and cognitive performance

1 reference

7 January 2021

Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine

1 reference

7 January 2021

Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease

1 reference

7 January 2021

Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.

1 reference

7 January 2021

Pathological verification of ischemic score in differentiation of dementias.

1 reference

7 January 2021

Homocysteine and B Vitamins Relate to Brain Volume and White-Matter Changes in Geriatric Patients With Psychiatric Disorders

1 reference

7 January 2021

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

7 January 2021

Homocysteine, folate deprivation and Alzheimer neuropathology.

1 reference

7 January 2021

Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study

1 reference

7 January 2021

Folic acid supplementation in dementia: a preliminary report

1 reference

7 January 2021

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

1 reference

7 January 2021

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.1856

1 reference

5 April 2018

1 reference

5 April 2018